27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Portola Pharmaceuticals Inc (NASDAQ:PTLA) investors should be marking Friday on their calendars.
Citi analyst Yigal Nochomovitz expects the Food and Drug Administration to release its decision on betrixaban on Friday, earlier than expected, as it has become a precedent for the FDA to release decisions before weekends/holidays.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Betrixaban supposedly reduces the risk of blood clots for patients who leave the hospital after a medical treatment. While Portola’s clinical data has not been great, with the drug failing its Phase 3 clinical trial, Portola has been able to push ahead for an FDA ruling.
Phase III Trial Not As Bad As It Sounds
According to an article on gurufocus, the drug should not be written off after the failed phase III trial, as it only failed in one particular subsection of patients. Specifically, for “patients that have been hospitalized for serious non-surgical conditions such as a heart attack, severe infection, stroke or a host of rheumatic disorders and that are at risk of developing a blood clot because of subsequent immobility.”
In the other two subsections, Betrixaban outperformed in phase III.
Update: Shares were halted at 11:18 a.m. ET. Traders began circulating an FDA document appearing to show FDA approval for Betrixaban.
Related Links:
Attention Bluebird Bio Investors: Analyst Sees Upside Following Strong Therapy Results
This Biotech Name Could Be Best In Breed For 2017
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.